# Anthem Biosciences Ltd (ANTHEM)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹769.1
Day Change: -1.46%
52W High: ₹873.25
52W Low: ₹579.45
Market Cap: ₹44,010 Cr

## Valuation
P/E: 91.74
P/B: 15.98
EPS: ₹8.54
Book Value: ₹49.04
Dividend Yield: 0%

## Returns
1Y Return: 15.06%

## Profitability
ROE: 0%
ROCE: 32.33%
Debt/Equity: 0.04
Revenue Growth: -15%
Profit Growth: -25.8%
EBITDA Margin: 36.8%
Operating Margin: 28.99%

## About
Anthem Biosciences Ltd is a Biotechnology company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Anthem Biosciences Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Quarterly Report: Board Meeting Intimation for Approve The Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2026, And To Consider Recommendation Of Final Dividend
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:00.503Z
Price History Updated: 2026-05-17T21:24:04.886Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:04.886Z
Quant Updated: 2026-05-17T21:24:04.886Z
Sentiment Updated: 2026-05-17T21:24:04.886Z
Financials Status: current
Financials Updated: 2026-05-19T01:14:53.974Z
Financials Last Attempt: 2026-05-19T01:14:53.974Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1844.55 Cr
Operating Profit: ₹592.15 Cr (OPM 32.1%)
Net Profit: ₹451.26 Cr
Tax: ₹205.61 Cr

## Annual P&L History
FY25: Rev ₹1844.55Cr | PAT ₹451.26Cr | OPM 32.1%
FY24: Rev ₹1419.37Cr | PAT ₹367.31Cr | OPM 29.92%
FY23: Rev ₹1056.92Cr | PAT ₹385.19Cr | OPM 35.17%

## Balance Sheet (FY25)
Total Assets: ₹2807.58 Cr
Total Liabilities: ₹397.72 Cr
Borrowings: ₹113.32 Cr
Cash: ₹316.14 Cr

## Shareholding
undefined: undefined%
undefined: undefined%

## Board
- Ajay  Bhardwaj B.Tech., M.S, Founder, Chairman, MD & CEO
- K. Ravindra Chandrappa, Co-Founder, COO & Executive Director
- Mohammed Gawir Baig, Chief Financial Officer
- Ganesh  Sambasivam, Chief Scientific Officer & Executive Director
- Divya  Prasad, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/anthem
Disclaimer: For research and education only. Not investment advice.